Abstract
31P magnetic resonance spectroscopy was performed in 16 medicated schizophrenic patients with neuroleptic-resistant marked positive symptoms and in 16 healthy volunteers matched for age and sex in order to determine what changes in phosphorus metabolites are detected in such patients as compared to the controls. The schizophrenic patients showed an increased level of phosphodiesters in the bilateral medial temporal lobes. They also showed a decrease in the level of β-ATP in the left medial temporal lobe. These findings suggest that schizophrenic patients with prominent positive symptoms refractory to neuroleptics may have a disturbance of bilateral membrane phospholipid and left-sided high-energy phosphate metabolism in the medial temporal lobe.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, revised. Washington DC, American Psychiatric Association
Andreasen NC (1984a) Scale for the assessment of negative symptoms (SANS). Iowa City, The University of Iowa
Andreasen NC (1984b) Scale for the assessment of positive symptoms (SAPS). Iowa City, The University of Iowa
Barta PE, Pearson GD, Powers RE, Richards SS, Tune LE (1990) Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147:1457–1462
Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G, Johns C, Masiar S (1993) Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 33:236–246
Bottomley PA (1989) Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe? Radiology 170:1–15
Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT (1993) Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 159:59–65
Calabrese G, Deicken RF, Fein G, Merrin EL, Schoenfeld F, Weiner MW (1992) 31 Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol Psychiatry 32:26–32
Davis JM (1976) Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33:858–861
DeLisi LE, Buchsbaum MS, Holcomb HH, Laugston KC, King AC, Kessler R, Pickar D, Carpenter WT, Morihisa JM, Margolin R, Weinberger DR (1989) Increased temporal lobe glucose use in chronic schizophrenic patients. Biol Psychiatry 25:835–851
Flor-Henry P (1976) Lateralized temporal-limbic dysfunction and psychopathology. Ann NY Acad Sci 280:777–797
Fujimoto T, Nakano T, Takano T, Hokazono Y, Asakura T, Tsuji T (1992) Study of chronic schizophrenics using31P magnetic resonance chemical shift imaging. Acta Psychatr Scand 86:455–462
Fukuzako H, Fukuzako T, Hashiguchi T, Hokazono Y, Takeuchi K, Hirakawa K, Ueyama K, Takigawa M, Ikeda K, Nakajo M, Fujimoto T (1994) Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: Assessment by MRI. Biol Psychiatry (in press)
Gattaz WF, Hübner CK, Nevalainen TJ, Thuren T, Kinnunen PKJ (1990) Increased serum phospholipase A2 activity in schizophrenia: A replication study. Biol Psychiatry 28:495–501
Kawasaki Y, Suzuki M, Maeda Y, Urata K, Yamaguchi N, Matsuda H, Hisada K, Suzuki M, Takashima T (1992) Regional cerebral blood flow in patients with schizophrenia: A preliminary report. Eur Arch Psychiatry Clin Neurosci, 241:195–200
Keshavan MS, Kapur S, Pettegrew JW (1991) Magnetic resonance spectroscopy in Psychiatry. Am J Psychiatry 148:976–985
Kilby PM, Allis JL, Radda GK (1990) Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain: the determination of the concentrations of phosphodiester components. FEBS Letters 272:163–165
Kishimoto H, Kuwahara H, Ohno S, Takazu O, Hama Y, Sato C, Ishii T, Nomura Y, Fujita H, Miyauchi T, Matsushita M, Yokoi S, Iio M (1987) Three subtypes of chronic shizophrenia identified using 11C-glucose positron emission tomography. Psychiatry Res 21:285–292
Klett CJ, Caffey E (1972) Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Arch Gen Psychiatry 26:374–379
Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ (1992) Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160:179–186
Lock T, Abou-saleh MT, Edwards RHT (1990) Psychiatry and the new magnetic resonance era. Br J Psychiatry 157:38–55
McCarley RW, Faux SF, Shenton M, LeMay M, Cane M Ballinger R, Duffy FH (1989) CT abnormalities in schizophrenia: A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms. Arch Gen Psychiatry 46:698–708
Miyazaki T (1992) Automatic baseline correction for31P-MRS. Jpn J Magn Reson Med 12:232–237
Morihisa JM, Duffy FH, Wyatt RJ (1983) Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiatry 40:718–727
Murphy EJ, Rajagopalan B, Brindle KM, Radda GK (1989) Phospholipid bilayer contribution to31P NMR spectrum in vivo. Magn Reson Med 12:282–289
O'Callaghan E, Redmond O, Ennis R, Stack J, Kinsella A, Ennis JT, Larkin C, Waddington JL (1991) Initial investigation of the left temporoparietal region in schizophrenia by31P magnetic resonance spectroscopy. Biol Psychiatry 29:1149–1152
Oldfield RC (1971) The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9:97–113
Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA, Raese JD (1990) Hypofrontality and cognitive impairment in schizophrenia: Dynamic singlephoton tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry 27:377–399
Pettegrew JW, Keshavan M, Panchalingam K (1989)31P NMR studies in schizophrenia. Biol Psychiatry 25:15A
Pettegrew JW, Panchalingam K, Withers G, McKeag D, Strychor S (1987) Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J Neuropathol Exp Neurol 49:237–249
Schachter SC, Ransil BJ, Geschwind N (1987) Associations of handedness with hair color and learning disabilities. Neuropsychologia 25:269–276
Schagass C, Roemer R (1991) Evoked potential topography in unmedicated and medicated schizophrenics. Int J Psychophysiol 10:213–224
Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW (1992) Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. N Engl J Med 327:604–612
Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR, Weinberger DR (1989) Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study. Am J Psychiatry 146:464–472
Weinberger DR, Berman KF, Suddath R, Torrey EF (1992) Evidence of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 149:890–897
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fukuzako, H., Takeuchi, K., Ueyama, K. et al. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms. Eur Arch Psychiatry Clin Nuerosci 244, 236–240 (1994). https://doi.org/10.1007/BF02190375
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02190375